Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
|Videos|November 14, 2016
Gary Shelton Addresses Myths About Palliative Cancer Care
Author(s)Gary Shelton, Ph.D.
Gary Shelton, Ph.D., coordinator of supportive oncology services at NYU Langone Medical Center, dispels the myth that being referred to palliative care means a patient is nearing end of life.
Advertisement
Gary Shelton, Ph.D., coordinator of supportive oncology services at NYU Langone Medical Center, dispels the myth that being referred to palliative care means a patient is nearing end of life.
Palliative care improves symptom burden and helps patients understand the disease trajectory. In fact, many patients who understand this even ask for a referral to palliative care.
Advertisement
Related to this article
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer.
Dr. Dina Khalaf breaks down three clinical trials testing oral and targeted regimens for acute myeloid leukemia and myelodysplastic syndrome.
Dr. Miguel Gonzales-Velez explains how placebos are used in phase 3 cancer trials, and why joining one does not mean giving up standard treatment.
Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.
Advertisement
Advertisement
Trending on CURE
1
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
2
5 Years of Leukemia Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
FDA Approves Inluriyo Plus Verzenio for Certain Advanced Breast Cancers
4
A Vaccine Grown From a Patient's Own Cells for Cancer in the Spinal Fluid
5